PTMD 2.0: an updated database of disease-associated post-translational modifications
Nucleic Acids Research · 06.01.2025 · 53 (D1) · D554-D563
DOI: 10.1093/nar/gkae850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.09.2024. Verfasst von Xinhe Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics and Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Luoyu Road 1…. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Databases, Protein. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of China, National Key R&D Program of China, Hubei Innovation Group Project.
Abstract (Originalsprache)
Various post-translational modifications (PTMs) participate in nearly all aspects of biological processes by regulating protein functions, and aberrant states of PTMs are frequently associated with human diseases. Here, we present a comprehensive database of PTMs associated with diseases (PTMD 2.0), including 342 624 PTM–disease associations (PDAs) in 15 105 proteins for 93 types of PTMs and 2083 diseases. Based on the distinct PTM states in diseases, we classified all PDAs into six categories: upregulation (U) or downregulation (D) of PTM levels, absence (A) or presence (P) of PTMs, and creation (C) or disruption (N) of PTM sites. We provided detailed annotations for each PDA and carefully annotated disease-associated proteins by integrating the knowledge from 101 additional resources that covered 13 aspects, including disease-associated information, variation and mutation, protein–protein interaction, protein functional annotation, DNA and RNA element, protein structure, chemical–target relationship, mRNA expression, protein expression/proteomics, subcellular localization, biological pathway annotation, functional domain annotation and physicochemical property. With a data volume of ∼8 GB, we anticipate that PTMD 2.0 will serve as a fundamental resource for further analysing the relationships between PTMs and diseases. The online service of PTMD 2.0 is freely available at https://ptmd.biocuckoo.cn/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioinformatics and Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Luoyu Road 1037, Wuhan 430074, China.
- Key Laboratory of Molecular Biophysics of Ministry of Education, Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Luoyu Ro…
- Nanjing University Institute of Artificial Intelligence Biomedicine, Xianlin Avenue 163, Nanjing 210031, China.
ORCID-Profile: Yu Xue
Förderung
- Natural Science Foundation of China
- National Key R&D Program of China
- Hubei Innovation Group Project
- Interdisciplinary Research Program of HUST
- Hubei Province Postdoctoral Outstanding Talent Tracking Support Program
- Research Core Facilities for Life Science (HUST)
Zitieren
APA
Huang, X., Feng, Z., Liu, D., Gou, Y., Chen, M., Tang, D., Han, C., Peng, J., Peng, D., & Xue, Y. (2025). PTMD 2.0: an updated database of disease-associated post-translational modifications. Nucleic Acids Research, 53(D1), D554-D563. https://doi.org/10.1093/nar/gkae850
Vancouver
Huang X, Feng Z, Liu D, Gou Y, Chen M, Tang D, et al. PTMD 2.0: an updated database of disease-associated post-translational modifications. Nucleic Acids Research. 2025;53(D1):D554-D563. doi:10.1093/nar/gkae850
BibTeX
@article{Huang2025,
author = {Huang, Xinhe and Feng, Zihao and Liu, Dan and Gou, Yujie and Chen, Miaomiao and Tang, Dachao and Han, Cheng and Peng, Jianzhen and Peng, Di and Xue, Yu},
title = {PTMD 2.0: an updated database of disease-associated post-translational modifications},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {D1},
pages = {D554--D563},
doi = {10.1093/nar/gkae850}
}
EUVIMED